GURUFOCUS.COM » STOCK LIST » Real Estate » Real Estate » Lushang Freda Pharmaceutical Co Ltd (SHSE:600223) » Definitions » 5-Year Yield-on-Cost %

Lushang Freda Pharmaceutical Co (SHSE:600223) 5-Year Yield-on-Cost % : 2.08 (As of Dec. 13, 2024)


View and export this data going back to 2000. Start your Free Trial

What is Lushang Freda Pharmaceutical Co 5-Year Yield-on-Cost %?

Lushang Freda Pharmaceutical Co's yield on cost for the quarter that ended in Sep. 2024 was 2.08.


The historical rank and industry rank for Lushang Freda Pharmaceutical Co's 5-Year Yield-on-Cost % or its related term are showing as below:

SHSE:600223' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.47   Med: 1.08   Max: 2.9
Current: 2.08


During the past 13 years, Lushang Freda Pharmaceutical Co's highest Yield on Cost was 2.90. The lowest was 0.47. And the median was 1.08.


SHSE:600223's 5-Year Yield-on-Cost % is ranked worse than
70.77% of 862 companies
in the Real Estate industry
Industry Median: 3.77 vs SHSE:600223: 2.08

Competitive Comparison of Lushang Freda Pharmaceutical Co's 5-Year Yield-on-Cost %

For the Real Estate - Development subindustry, Lushang Freda Pharmaceutical Co's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lushang Freda Pharmaceutical Co's 5-Year Yield-on-Cost % Distribution in the Real Estate Industry

For the Real Estate industry and Real Estate sector, Lushang Freda Pharmaceutical Co's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Lushang Freda Pharmaceutical Co's 5-Year Yield-on-Cost % falls into.



Lushang Freda Pharmaceutical Co 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Lushang Freda Pharmaceutical Co is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5

Lushang Freda Pharmaceutical Co  (SHSE:600223) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


Lushang Freda Pharmaceutical Co 5-Year Yield-on-Cost % Related Terms

Thank you for viewing the detailed overview of Lushang Freda Pharmaceutical Co's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.


Lushang Freda Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
No. 9777 Jingshi Road, Building 5, Lixia District, Jinan City, CHN
Lushang Freda Pharmaceutical Co Ltd formerly Lushang Health Industry Development Co Ltd is a real estate developer in China. The company is engaged in the development of office buildings, infrastructure, apartments, and hotels.
Executives
Li Hang senior management
Yin Wei Directors, senior managers
Shao Zhao Wei senior management
Wang Zhong Wu senior management
Dong Hong Lin Director
Zhou Hong Bo senior management
Li Lu senior management
Liu Zeng Wei senior management
Zhang Quan Li senior management
Xu Tao senior management
Ju Hai Bo Director
Zhao Xi Liang Director
Pi Xi Cai Supervisors

Lushang Freda Pharmaceutical Co Headlines

No Headlines